K
Kevin L.M. Chua
Researcher at National University of Singapore
Publications - 10
Citations - 148
Kevin L.M. Chua is an academic researcher from National University of Singapore. The author has contributed to research in topics: SABR volatility model & Radiation therapy. The author has an hindex of 2, co-authored 10 publications receiving 30 citations.
Papers
More filters
Journal ArticleDOI
Revisiting neoadjuvant therapy in non-small-cell lung cancer.
Stephanie P L Saw,Boon-Hean Ong,Kevin L.M. Chua,Angela Takano,Daniel S.W. Tan,Daniel S.W. Tan +5 more
TL;DR: In this article, a biomarker-driven approach for early-stage non-small-cell lung cancer (NSCLC) has been proposed to improve survival outcomes in early stage NSCLC.
Journal ArticleDOI
Stereotactic Ablative Radiotherapy for the Management of Spinal Metastases: A Review.
Rachel Glicksman,Michael C. Tjong,Wellington Furtado Pimenta Neves-Junior,Daniel E. Spratt,Kevin L.M. Chua,Alireza Mansouri,Melvin L.K. Chua,Alejandro Berlin,Alejandro Berlin,Jeff Winter,Max Dahele,Ben J. Slotman,Mark H. Bilsky,David B. Shultz,David B. Shultz,Marcos Vinicius Calfat Maldaun,Nicholas J. Szerlip,Simon S. Lo,Yoshiya Yamada,Francisco E. Vera-Badillo,Gustavo Nader Marta,Fabio Y. Moraes +21 more
TL;DR: It is suggested that spinal SABR may be an effective treatment option for well-selected patients with spinal metastases, achieving high rates of local tumor control with moderate rates of adverse effects.
Journal ArticleDOI
Vandetanib sensitizes head and neck squamous cell carcinoma to photodynamic therapy through modulation of EGFR-dependent DNA repair and the tumour microenvironment.
Pek Lim Chu,Waseem Ahamed Shihabuddeen,Kar Perng Low,Dennis J.J. Poon,Bhuvaneswari Ramaswamy,Zhong-Guo Liang,Wen Long Nei,Kevin L.M. Chua,Patricia S. P. Thong,Khee Chee Soo,Eugenia Li Ling Yeo,Melvin L.K. Chua +11 more
TL;DR: Vandetanib enhances the efficacy of PDT through both direct and indirect effects on the cellular DNA repair machinery and tumour microenvironment, respectively, corroborating the importance of microenvironmental modification for the observed drug-PDT synergistic interaction.
Journal ArticleDOI
An International Expert Survey on the Indications and Practice of Radical Thoracic Reirradiation for Non-Small Cell Lung Cancer.
Robert Rulach,Robert Rulach,David Ball,Kevin L.M. Chua,Max Dahele,Dirk De Ruysscher,Kevin Franks,Daniel R. Gomez,Matthias Guckenberger,Gerard G Hanna,Alexander V. Louie,Drew Moghanaki,David A. Palma,Clive Peedell,Ahmed Salem,Shankar Siva,Gregory M.M. Videtic,Anthony J. Chalmers,Anthony J. Chalmers,Stephen Harrow,Stephen Harrow +20 more
TL;DR: In this paper, the Delphi consensus process was used to develop expert consensus guidance on the safe practice of treating non-small cell lung cancer with radiation therapy in the setting of prior thoracic irradiation.
Journal ArticleDOI
Efficacy and safety of apatinib in recurrent/metastatic nasopharyngeal carcinoma: A pilot study.
Luo Huang,Xin Zhang,Yu Bai,Kevin L.M. Chua,Yue Xie,Xiaolei Shu,Bin Long,Chunbo Fan,Darren W.T. Lim,Sze Huey Tan,Joseph Wee,Ying Wang,Yongzhong Wu,Melvin L.K. Chua +13 more
TL;DR: In this paper, the efficacy and safety data of apatinib in rmNPC patients were reported, which indicated potential efficacy of the drug in rmNC patients, although adverse effects were low.